171 related articles for article (PubMed ID: 36180546)
1. Histiocytic Disorders of Childhood.
Eckstein OS; Picarsic J; Allen CE
Pediatr Rev; 2022 Oct; 43(10):561-571. PubMed ID: 36180546
[TBL] [Abstract][Full Text] [Related]
2. Histiocytic disorders.
McClain KL; Bigenwald C; Collin M; Haroche J; Marsh RA; Merad M; Picarsic J; Ribeiro KB; Allen CE
Nat Rev Dis Primers; 2021 Oct; 7(1):73. PubMed ID: 34620874
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.
Allen CE; Parsons DW
Hematology Am Soc Hematol Educ Program; 2015; 2015():559-64. PubMed ID: 26637772
[TBL] [Abstract][Full Text] [Related]
4. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
[TBL] [Abstract][Full Text] [Related]
5. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
Haroche J; Abla O
Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
[TBL] [Abstract][Full Text] [Related]
6. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.
Chakraborty R; Hampton OA; Shen X; Simko SJ; Shih A; Abhyankar H; Lim KP; Covington KR; Trevino L; Dewal N; Muzny DM; Doddapaneni H; Hu J; Wang L; Lupo PJ; Hicks MJ; Bonilla DL; Dwyer KC; Berres ML; Poulikakos PI; Merad M; McClain KL; Wheeler DA; Allen CE; Parsons DW
Blood; 2014 Nov; 124(19):3007-15. PubMed ID: 25202140
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cell histiocytosis: Version 2021.
Gulati N; Allen CE
Hematol Oncol; 2021 Jun; 39 Suppl 1(Suppl 1):15-23. PubMed ID: 34105821
[TBL] [Abstract][Full Text] [Related]
8. OCT2 expression in histiocytoses.
Ungureanu IA; Cohen-Aubart F; Héritier S; Fraitag S; Charlotte F; Lequain H; Hélias-Rodzewicz Z; Haroche J; Donadieu J; Emile JF
Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
[TBL] [Abstract][Full Text] [Related]
9. Fetal and neonatal histiocytoses.
Isaacs H
Pediatr Blood Cancer; 2006 Aug; 47(2):123-9. PubMed ID: 16416419
[TBL] [Abstract][Full Text] [Related]
10. Hemophagocytic Lymphohistiocytosis in Langerhans Cell Histiocytosis: A Case Series and Literature Review.
Tang X; Guo X; Gao J; Sun JJ; Wan Z
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e20-e25. PubMed ID: 34133378
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous adult xanthogranuloma with a small portion of BRAF
Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
[TBL] [Abstract][Full Text] [Related]
12. An unusual co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: report of a case and review of the literature.
Cohen-Barak E; Rozenman D; Schafer J; Krausz J; Dodiuk-Gad R; Gabriel H; Shani-Adir A
Int J Dermatol; 2014 May; 53(5):558-63. PubMed ID: 23968608
[TBL] [Abstract][Full Text] [Related]
13. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
14. Pediatric liver failure with massive sinusoidal infiltration of histiocytes.
Irie R; Shioda Y; Osumi T; Sakamoto KI; Kasahara M; Matsumoto K; Nakazawa A
J Clin Exp Hematop; 2022 Mar; 62(1):25-34. PubMed ID: 34840207
[TBL] [Abstract][Full Text] [Related]
15. Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses.
Weitzman S; Jaffe R
Pediatr Blood Cancer; 2005 Sep; 45(3):256-64. PubMed ID: 15547923
[TBL] [Abstract][Full Text] [Related]
16. Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytoses.
Mavrogenis AF; Igoumenou VG; Antoniadou T; Megaloikonomos PD; Agrogiannis G; Foukas P; Papageorgiou SG
EFORT Open Rev; 2018 Jun; 3(6):381-390. PubMed ID: 30034819
[TBL] [Abstract][Full Text] [Related]
17. Pediatric lymphomas and histiocytic disorders of childhood.
Allen CE; Kelly KM; Bollard CM
Pediatr Clin North Am; 2015 Feb; 62(1):139-65. PubMed ID: 25435117
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai-Dorfman disease.
Wang KH; Cheng CJ; Hu CH; Lee WR
Br J Dermatol; 2002 Oct; 147(4):770-4. PubMed ID: 12366428
[TBL] [Abstract][Full Text] [Related]
19. A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.
Chellapandian D; Hines MR; Zhang R; Jeng M; van den Bos C; Santa-María López V; Lehmberg K; Sieni E; Wang Y; Nakano T; Williams JA; Fustino NJ; Astigarraga I; Dunkel IJ; Abla O; van Halteren AGS; Pei D; Cheng C; Weitzman S; Sung L; Nichols KE
Cancer; 2019 Mar; 125(6):963-971. PubMed ID: 30521100
[TBL] [Abstract][Full Text] [Related]
20. [An overview of histiocytosis].
Tojo A
Rinsho Ketsueki; 2022; 63(5):363-367. PubMed ID: 35662158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
